Aurobindo Pharma Ltd, a active public limited company, was established on 26 December 1986 in Hyderabad, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24239TG1986PLC015190. Registered under ROC Roc Hyderabad. it is listed on BSE: 524804 and NSE: AUROPHARMA. It has an authorized capital of ₹666.40 Cr and a paid-up capital of ₹58.08 Cr.
Formerly known as Aurobindo Pharma Pvt Ltd. It upholds a compliant status. In 2024, it reported revenue of ₹11,261.70 Cr and a net worth of ₹19,722.82 Cr. Employing 15,925 professional, Its leadership includes Santanu Mukherjee (Director), Deepali Pant Rajeev Joshi (Director), Nityananda Reddy Kambam (Managing Director). Past directors included Channa Reddy C, Ravindra Yogesh Shenoy, Rangaswamy Rathakrishnan Iyer. It holds ₹2,000.00 Cr open charges and ₹4,387.54 Cr settled loans. Its latest AGM occurred on 10 September 2025, with the balance sheet filed on 31 March 2025. It is based at Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet,, Hyderabad, Telangana, 500038.
L24239TG1986PLC015190
015190
26 December 1986
₹666.40 Cr
₹58.08 Cr
Roc Hyderabad
Listed (BSE: 524804, NSE: AUROPHARMA)
Active
Explore comprehensive insights into Aurobindo Pharma Ltd — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Santanu Mukherjee | Director | 09 Feb 2023 | Current |
| Deepali Pant Rajeev Joshi | Director | 10 Feb 2024 | Current |
| Nityananda Reddy Kambam | Managing Director | 30 Dec 1992 | Current |
| Madan Mohan Reddy Mettu | Whole-Time Director | 01 Jan 2013 | Current |
| Venkata Ramprasad Reddy Penaka | Director | 30 Dec 1992 | Current |
| Satakarni Makkapati | Director | 09 Nov 2023 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 07 Aug 2012 | Past |
| Pramod Abcsdd | Additional Director | 01 Jun 2012 | Past |
| Pramod Abcsdd | Additional Director | 31 Aug 2017 | Past |
| Pramod Abcsdd | Additional Director | 31 Mar 2023 | Past |
| Pramod Abcsdd | Director | 29 Aug 2018 | Past |
| Pramod Abcsdd | Managing Director | 01 Jan 2022 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aurobindo Pharma Ltd, for the financial year ended 2024, experienced significant reduction in revenue, with a 14.85% decrease. The company also saw a substantial improvement in profitability, with a 58.82% increase in profit. The company's net worth Soared by an impressive increase of 10.1%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Aurobindo Pharma had a promoter holding of 51.84% and a public holding of 48.18%. The company had 17 Subsidiaries, 2 Joint Ventures and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹20,000,000,000.00
₹43,875,437,500.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Jun 1997 | State Bank Of India | ₹2,000.00 Cr | Open |
| 08 Jan 2013 | Dbs Bank Ltd | ₹164.00 Cr | Satisfied |
| 25 May 2012 | Ifci Limited | ₹156.00 Cr | Satisfied |
| 25 May 2012 | Ifci Limited | ₹130.00 Cr | Satisfied |
| 28 Feb 2011 | Axis Bank Limited | ₹37.98 Cr | Satisfied |
Explore comprehensive loan charge details -
Aurobindo Pharma has a workforce of 15925 employees as of Aug 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Aurobindo Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurobindo Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Aurobindo Pharma Ltd last Annual general meeting of members was held on 10 Sep 2025 as per latest MCA records. was documented.
Aurobindo Pharma Ltd has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was recorded as a recent event.
Progress on Mangalam Ramasubramanian Kumar was appointed as a Director was appointed as a Director on 01 Apr 2024 & has been associated with this company since 1 year 8 months . was documented.
The activity Deepali Pant Rajeev Joshi was appointed as a Director was appointed as a Director on 10 Feb 2024 & has been associated with this company since 1 year 9 months . was completed.
The activity Satakarni Makkapati was appointed as a Director was appointed as a Director on 09 Nov 2023 & has been associated with this company since 2 years 24 days . was completed.
Progress on A charge with State Bank Of India of Rs. 2,000.00 Cr registered on 05 Jun 1997 with Charge ID 80013576 was modified on 22 Feb 2023. was documented.
The CIN of Aurobindo Pharma Ltd is L24239TG1986PLC015190.
Aurobindo Pharma Ltd is headquartered at Plot No.2, Maithrivihar, Behind Maithri Vanam, Ameerpet,, Hyderabad, Telangana, 500038.
Aurobindo Pharma Ltd was incorporated on 26 December 1986.
The current directors of Aurobindo Pharma Ltd are
The primary industry of Aurobindo Pharma Ltd is Manufacturing.
Aurobindo Pharma Ltd is listed. It is listed on BSE: 524804 and NSE: AUROPHARMA.
The authorized capital of Aurobindo Pharma Ltd is ₹666.40 Cr, and the paid-up capital is ₹58.08 Cr.
The compliance status of Aurobindo Pharma Ltd is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX